Tomasz Sacha

2.8k total citations
95 papers, 727 citations indexed

About

Tomasz Sacha is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Tomasz Sacha has authored 95 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Hematology, 61 papers in Genetics and 28 papers in Rheumatology. Recurrent topics in Tomasz Sacha's work include Chronic Myeloid Leukemia Treatments (62 papers), Chronic Lymphocytic Leukemia Research (42 papers) and Eosinophilic Disorders and Syndromes (27 papers). Tomasz Sacha is often cited by papers focused on Chronic Myeloid Leukemia Treatments (62 papers), Chronic Lymphocytic Leukemia Research (42 papers) and Eosinophilic Disorders and Syndromes (27 papers). Tomasz Sacha collaborates with scholars based in Poland, Germany and France. Tomasz Sacha's co-authors include Giuseppe Saglio, Aleksander B. Skotnicki, Timothy P. Hughes, Anna Turkina, Jeffrey H. Lipton, Naoto Takahashi, Dong‐Wook Kim, Nelma Cristina D. Clementino, Jolanta Dengler and Vasily Shuvaev and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Tomasz Sacha

80 papers receiving 712 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomasz Sacha Poland 14 466 406 205 175 134 95 727
Kara Johnson United States 15 607 1.3× 472 1.2× 337 1.6× 313 1.8× 114 0.9× 19 978
R E Clark United Kingdom 15 466 1.0× 304 0.7× 165 0.8× 145 0.8× 282 2.1× 24 821
M B Agarwal India 8 632 1.4× 582 1.4× 229 1.1× 52 0.3× 76 0.6× 44 761
Robyn M. Scherber United States 17 597 1.3× 796 2.0× 377 1.8× 499 2.9× 96 0.7× 68 1.1k
Florence Hourcade‐Potelleret Switzerland 16 183 0.4× 223 0.5× 51 0.2× 130 0.7× 195 1.5× 27 567
Abdulkadyrov Km Russia 11 776 1.7× 282 0.7× 58 0.3× 391 2.2× 417 3.1× 87 996
Xuejun Chen China 14 112 0.2× 124 0.3× 44 0.2× 117 0.7× 161 1.2× 38 545
Michael L. Tidwell United States 11 512 1.1× 144 0.4× 29 0.1× 573 3.3× 305 2.3× 16 952
Sven‐Aage Killmann Denmark 17 432 0.9× 210 0.5× 136 0.7× 284 1.6× 127 0.9× 39 848
Mirosław Markiewicz Poland 14 335 0.7× 68 0.2× 29 0.1× 75 0.4× 117 0.9× 67 680

Countries citing papers authored by Tomasz Sacha

Since Specialization
Citations

This map shows the geographic impact of Tomasz Sacha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Sacha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Sacha more than expected).

Fields of papers citing papers by Tomasz Sacha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomasz Sacha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Sacha. The network helps show where Tomasz Sacha may publish in the future.

Co-authorship network of co-authors of Tomasz Sacha

This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Sacha. A scholar is included among the top collaborators of Tomasz Sacha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Sacha. Tomasz Sacha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bellosillo, Beatríz, Michael Doubek, Ciprian Tomuleasa, et al.. (2024). JAK2 mutations in polycythemia vera: from molecular origins to inflammatory pathways and clinical implications. memo - Magazine of European Medical Oncology. 17(S4). 79–93.
2.
Sacha, Tomasz, et al.. (2024). Current status of hydroxyurea in treatment of polycythemia vera. Acta Haematologica Polonica. 55(3). 145–150.
3.
Sacha, Tomasz & Katarzyna Krawczyk. (2024). Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies. Hematology Transfusion and Cell Therapy. 47(1). 103675–103675.
4.
Oh, Stephen T., Srđan Verstovšek, Vikas Gupta, et al.. (2024). Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis. SHILAP Revista de lepidopterología. 5(1). 105–116. 12 indexed citations
5.
Gupta, Vikas, Stephen T. Oh, Timothy Devos, et al.. (2023). POSTER: MPN-551 Clinical Outcomes With Momelotinib vs Ruxolitinib in Patients With Myelofibrosis and Anemia: Subgroup Analysis of SIMPLIFY-1. Clinical Lymphoma Myeloma & Leukemia. 23. S192–S192. 1 indexed citations
6.
Giza, Agnieszka, et al.. (2023). Immediate Response to Brentuximab Vedotin in a Patient with Localized MF-LCT. Case Reports in Dermatology. 15(1). 110–116.
7.
Piątkowska‐Jakubas, Beata, et al.. (2023). The Complexities of Diagnosis with Co-Existing Gaucher Disease and Hemato-Oncology—A Case Report and Review of the Literature. Journal of Clinical Medicine. 12(17). 5518–5518. 2 indexed citations
8.
Verstovšek, Srđan, Ruben A. Mesa, Vikas Gupta, et al.. (2023). Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials. Blood Advances. 7(14). 3582–3591. 25 indexed citations
9.
Dybaś, Jakub, Aleksandra Wajda, Magdalena Kaczmarska, et al.. (2022). Label-free testing strategy to evaluate packed red blood cell quality before transfusion to leukemia patients. Scientific Reports. 12(1). 21849–21849. 3 indexed citations
10.
Hughes, Timothy P., Nelma Cristina D. Clementino, Jeffrey H. Lipton, et al.. (2021). Long-term treatment-free remission in patients with chronic myeloid leukemia after second-line nilotinib: ENESTop 5-year update. Leukemia. 35(6). 1631–1642. 26 indexed citations
11.
Kaczmarska, Magdalena, Ewa Szczęsny-Małysiak, Aleksandra Wajda, et al.. (2021). An Insight into the Stages of Ion Leakage during Red Blood Cell Storage. International Journal of Molecular Sciences. 22(6). 2885–2885. 5 indexed citations
12.
13.
Kaczmarska, Magdalena, Marek Grosicki, Katarzyna Bułat, et al.. (2020). Temporal sequence of the human RBCs' vesiculation observed in nano-scale with application of AFM and complementary techniques. Nanomedicine Nanotechnology Biology and Medicine. 28. 102221–102221. 12 indexed citations
14.
Sacha, Tomasz. (2020). 1.3. Przewlekła białaczka szpikowa. 6. 38–54.
15.
Sacha, Tomasz, et al.. (2020). Long-Term Outcomes of Imatinib Real-Life Treatment for Chronic Myeloid Leukemia- a 20-Year Review. Blood. 136(Supplement 1). 52–53. 1 indexed citations
16.
Cortes, Jörge E., Cármino Antônio De Souza, Manuel Ayala, et al.. (2016). Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trial. The Lancet Haematology. 3(12). e581–e591. 26 indexed citations
17.
Sacha, Tomasz. (2013). IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW. Mediterranean Journal of Hematology and Infectious Diseases. 6(1). e2014007–e2014007. 81 indexed citations
18.
Sacha, Tomasz, J. Hartwich, Anna Polus, et al.. (2005). The effect of β-carotene and its derivatives on cytotoxicity, differentiation, proliferative potential and apoptosis on the three human acute leukemia cell lines: U-937, HL-60 and TF-1. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1740(2). 206–214. 21 indexed citations
19.
Bodzioch, Marek, A. Dembińska-Kieć, J. Hartwich, et al.. (2005). The Microarray Expression Analysis Identifies BAX as a Mediator of β-Carotene Effects on Apoptosis. Nutrition and Cancer. 51(2). 226–235. 9 indexed citations
20.
Szczeklik, Andrzej, et al.. (1992). Plasma fibrinolytic activity in healthy subjects with high and low lipoprotein(a) concentrations. Thrombosis Research. 66(4). 391–395. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kara Johnson Breakdown of academic impact, for papers by R E Clark Breakdown of academic impact, for papers by M B Agarwal Breakdown of academic impact, for papers by Robyn M. Scherber Breakdown of academic impact, for papers by Florence Hourcade‐Potelleret Breakdown of academic impact, for papers by Abdulkadyrov Km Breakdown of academic impact, for papers by Xuejun Chen Breakdown of academic impact, for papers by Michael L. Tidwell Breakdown of academic impact, for papers by Sven‐Aage Killmann Breakdown of academic impact, for papers by Mirosław Markiewicz
Rankless by CCL
2026